Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Novartis Corporation, a leading global healthcare company, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines, generics, and biosimilars.
The company is renowned for its core products, including advanced therapies in oncology, cardiology, and immunology, which are distinguished by their cutting-edge research and development. Novartis has achieved significant milestones, such as the introduction of groundbreaking treatments that have transformed patient care. With a strong market position, Novartis continues to be recognised for its commitment to improving global health and advancing medical science.
+66 vs industry average
Novartis Corporation’s score of 97 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chemicals is among the most carbon-intensive industries
The Chemicals industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for Novartis Corporation yet.
As of the latest available data, Novartis Corporation does not report specific carbon emissions figures, indicating a lack of detailed emissions data for the most recent year. The company is a current subsidiary of Novartis AG, which may influence its climate commitments and reporting practices.
Novartis AG, the parent organisation, has established various climate initiatives and targets that cascade down to Novartis Corporation. These include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all aimed at reducing carbon emissions and promoting sustainability. However, specific reduction targets or achievements for Novartis Corporation itself are not detailed in the available information.
The absence of direct emissions data suggests that Novartis Corporation may still be in the process of developing or implementing its own specific climate strategies, while aligning with the broader goals set by Novartis AG. The company is expected to adhere to industry standards in climate terminology and practices as it works towards enhancing its environmental performance.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Novartis Corporation yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Novartis Corporation yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more